WDR35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.70663999999876E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.456200E-03 |
Normal-vs-Stage2 |
7.600700E-03 |
Normal-vs-Stage3 |
1.37540000000325E-06 |
Normal-vs-Stage4 |
2.98430000045258E-07 |
Stage1-vs-Stage2 |
2.944400E-01 |
Stage1-vs-Stage3 |
4.520900E-03 |
Stage1-vs-Stage4 |
1.804860E-03 |
Stage2-vs-Stage3 |
3.261600E-01 |
Stage2-vs-Stage4 |
1.508410E-01 |
Stage3-vs-Stage4 |
5.854600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.77542999999503E-05 |
Normal-vs-AfricanAmerican |
4.264500E-03 |
Normal-vs-Asian |
3.446400E-01 |
Caucasian-vs-AfricanAmerican |
9.071400E-01 |
Caucasian-vs-Asian |
6.175400E-01 |
AfricanAmerican-vs-Asian |
5.890800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.72489999973014E-07 |
Normal-vs-Female |
6.215500E-03 |
Male-vs-Female |
4.936500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.644900E-03 |
Normal-vs-Age(41-60Yrs) |
7.71649999999902E-05 |
Normal-vs-Age(61-80Yrs) |
1.964540E-04 |
Normal-vs-Age(81-100Yrs) |
2.460100E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.563800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.739800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.396400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.473800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.602200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.650600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.600000E-01 |
Normal-vs-Grade 2 |
7.136300E-02 |
Normal-vs-Grade 3 |
9.79459999994603E-07 |
Normal-vs-Grade 4 |
5.07460740095667E-12 |
Grade 1-vs-Grade 2 |
4.756400E-01 |
Grade 1-vs-Grade 3 |
2.841900E-02 |
Grade 1-vs-Grade 4 |
6.45659999999326E-05 |
Grade 2-vs-Grade 3 |
9.842800E-04 |
Grade 2-vs-Grade 4 |
1.44419998182599E-09 |
Grade 3-vs-Grade 4 |
4.629300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.525800E-01 |
Normal-vs-ccB subtype |
5.94039994972206E-09 |
ccA subtype-vs-ccB subtype |
8.02050004189425E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.574200E-04 |
Normal-vs-N1 |
4.359600E-03 |
N0-vs-N1 |
4.374000E-01 |
|
|